Cellectar Biosciences (CLRB) Q3 2023 Earnings

13NovConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-1
-0.81
-0.63
-0.44

Details

Expected EPS
-0.44
Actual EPS
-0.82
Surprise EPS
-0.38
Surprise Percent
+86.36%

Description

Cellectar Biosciences (CLRB) has reported earnings of -0.82 per share for Q3 2023.

0 Comments

Share your thoughts